Registration Now Open - 20th Annual ABC 7 Jim Gibbons 5K

January 2014 (CHICAGO) NEWS RELEASE

Registration for the 20th Annual ABC 7 Jim Gibbons 5K is now open. The event takes place in Chicago's Lincoln Park - 2601 N. Cannon Drive in Chicago (60614), adjacent to Diversey Harbor, on Thursday, June 12. Register at www.Gibbons5K.com. Proceeds from the event benefit the Leukemia Research Foundation (LRF).

The event was created to honor the memory of Jim Gibbons, a 25-year veteran investigative reporter for ABC 7 who succumbed to leukemia in 1994.

The online registration fee is $35 for adult runners who choose to be chip-timed, $30 for 5K fun run and 3K walk, and $15 for children (14 and under) 5K run and 3K walk. Discounted registration is available until April 1. Teams also register online at www.Gibbons5K.com.

Event sponsorships are still available. Contact Cindy Kane at Cindy@LRFmail.org or call 847-424-0600. The Leukemia Research Foundation acknowledges ABC 7 Chicago for renewing its commitment to the fight against blood cancers.

Stay up-to-date about pre-event parties, packet pickup and more through the ABC 7 Jim Gibbons 5K page on Facebook.

About The Leukemia Research Foundation (LRF)
The Leukemia Research Foundation, headquartered in Wilmette, Ill., is committed to funding research and providing support to people affected by blood cancers. The Leukemia Research Foundation is dedicated to conquering ALL blood cancers by funding research into their causes and cures, and enriching the quality of life of those touched by these diseases. For 68 years, thousands of volunteers and 23 chapters have helped the Foundation raise more than $56 million to help fund research specifically targeting aspiring, eager, and innovative scientists and physicians around the world, provide patient financial assistance, and offer educational and emotional support for patients and their families.

Leukemia Research Foundation information is available at www.allbloodcancers.org, or by calling 847-424-0600.

Copyright © 2024 WLS-TV. All Rights Reserved.